US FDA Ad/Promo Crackdown Letters Came From OPDP Staff, Not Artificial Intelligence

 
• By Sue Sutter
  
Padlock
A former OPDP official worries about intellectual property protections for ad/promo submissions to the FDA. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from United States